PTK2 and cancer: Moreover, MUC16 is associated with PDAC malignant progression, and that truncated O-glycans containing MUC16 activate FAK signaling through specific interactions with α4 and β1 integrin complexes on cancer cell membranes, contributing to PDAC malignancy progress (Rajesh et al., 2022).